ADPGK-AS1 has been shown to inhibit miR-205-5p downregulation in pancreatic cancer, which is negatively correlated with cancer cell proliferation, migration, and invasion, and positively correlated with apoptosis rates. Here, ADPGK is linked to pancreatic neoplasm.